What is the Fiscal Year for iBio?
Date: November 14, 2026
iBio's current fiscal year starts on July 1, 2026, and ends on June 30, 2027. Their current quarter is Q2, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
July 1, 2026
Fiscal Year End
June 30, 2027
Current Quarter
Q2
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jul 1, 2026 – Sep 30, 2026
Q2
Oct 1, 2026 – Dec 31, 2026
Q3
Jan 1, 2027 – Mar 31, 2027
Q4
Apr 1, 2027 – Jun 30, 2027
Company Information
Headquarters
San Diego, California, United States
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
IBIO
Website
https://ibioinc.comDescription
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like iBio and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.